Hyperion Therapeutics' P2P Acquisition

Hyperion Therapeutics raised a round of funding on March 30, 2015. Investors include Horizon Pharma.

Hyperion Therapeutics is a privately held specialty therapeutics company focused on the development of therapies that address needs in the areas of gastroenterology and hepatology. In partnership with…

Articles about Hyperion Therapeutics' P2P Acquisition: